Galapagos Partners with Blood Centers of America to Decentralize CAR-T Production

Belgian biotech Galapagos announced on Wednesday that it is enlisting Blood Centers of America in its strategic goal of decentralizing the manufacturing of CAR-T cell therapeutics in the United States.